← All organizations

Trinity Hypertension & Metabolic Research Institute

Academic/Hospital

Also known as: Trinity Hypertension & Metabolic Research Institute

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Dec 1, 2024

Timeline

No events for the selected filters.

Drugs by trial phase (5 distinct, 4 trials)

Phase 4 (4 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

cannabidiol

Indications

Studied for

Recent trials (8)

NCT06656806Lead sponsorEarly Phase 1Dec 1, 2024
NCT06656806Sponsor investigatorEarly Phase 1Dec 1, 2024
NCT05644769Sponsor investigatorPhase 4Nov 15, 2022
NCT05644769Lead sponsorPhase 4Nov 15, 2022
NCT05644769Reponsible party - principal investigatorPhase 4Nov 15, 2022
NCT03180593Reponsible party - principal investigatorPhase 4Feb 7, 2017
NCT03180593Lead sponsorPhase 4Feb 7, 2017
NCT03635125Lead sponsorPhase 4Aug 30, 2010

Details

Last known activity: Dec 1, 2024